Literature DB >> 23596992

Translation and validation of the Danish version of the Patient Rated Wrist Evaluation questionnaire.

Jesper O Schønnemann1, Torben B Hansen, Kjeld Søballe.   

Abstract

The need for validated outcome measures is increasing. The purpose is to translate and validate the Patient Rated Wrist Evaluation (PRWE) in Danish. Translation was done by an expert panel followed by evaluation of a lay panel and a field test on 10 patients. Sixty patients with wrist fractures were included. Both lay panel comments and field test revealed issues not dealt with by the expert panel, and a final version of the Danish PRWE was made. The validation process then continued and reliability results. were presented as Cronbach's alpha = 0.94, describing the homogeneity and the intraclass correlation coefficient = 0.88 and difference of mean = 5.7 (CI = 1.12-10.37, p = 0.017), describing the concordance of the results. Convergent validity at first and last control was for pain, 0.51 and 0.46, and physical mobility, 0.56 and 0.64, respectively, describing the correlation with a gold standard questionnaire. A minor floor effect was noticed, but not enough to indicate a lack of sensitivity of the PRWE. Effect size, the ability to measure sensitivity to change, was 0.62, also described as responsiveness. The translation resulted in a questionnaire that represents correct easy-understandable Danish. It is concluded that the modified Danish version is a valid questionnaire for patients with wrist fractures.

Entities:  

Mesh:

Year:  2013        PMID: 23596992     DOI: 10.3109/2000656X.2013.787934

Source DB:  PubMed          Journal:  J Plast Surg Hand Surg        ISSN: 2000-6764


  7 in total

1.  Psychometric Properties of the Persian Version of the Patient Rated Wris t Evaluation.

Authors:  Golnaz Ghayyem Hassankhani; Ali Moradi; Ehsan Vahedi; Sayyed Hadi Sayyed Hoseinian; Zohreh Jahani; Maedeh Rahmani; Mohammad H Ebrahimzadeh
Journal:  Arch Bone Jt Surg       Date:  2017-07

2.  Cross‑cultural adaptation, construct validity, reliability, and responsiveness of the Thai version of the Patient-Rated Wrist/Hand Evaluation (Thai PRWHE).

Authors:  Pichitchai Atthakomol; Worapaka Manosroi; Aphiwij Mongkonkamthon; Peeradech Buranaworathitikul; Wilailak Wongcharoen; Siam Tongprasert; Tinakon Wongpakaran
Journal:  Qual Life Res       Date:  2021-01-27       Impact factor: 4.147

3.  Patient-Rated Wrist Evaluation: Spanish Version and Evaluation of Its Psychometric Properties in Patients with Acute Distal Radius Fracture.

Authors:  Veronica Alfie; Gerardo Gallucci; Jorge Boretto; Agustin Donndorff; Juieta Puig Dubois; Sonia Benitez; Diego Giunta; Pablo de Carli
Journal:  J Wrist Surg       Date:  2017-03-08

4.  The Spanish version of the Patient-Rated Wrist Evaluation outcome measure: cross-cultural adaptation process, reliability, measurement error and construct validity.

Authors:  Roberto S Rosales; Rayco García-Gutierrez; Luis Reboso-Morales; Isam Atroshi
Journal:  Health Qual Life Outcomes       Date:  2017-08-24       Impact factor: 3.186

5.  Are validated outcome measures used in distal radial fractures truly valid? A critical assessment using the COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) checklist.

Authors:  Y V Kleinlugtenbelt; R W Nienhuis; M Bhandari; J C Goslings; R W Poolman; V A B Scholtes
Journal:  Bone Joint Res       Date:  2016-04       Impact factor: 5.853

6.  Are the patient-rated wrist evaluation (PRWE) and the disabilities of the arm, shoulder and hand (DASH) questionnaire used in distal radial fractures truly valid and reliable?

Authors:  Y V Kleinlugtenbelt; R G Krol; M Bhandari; J C Goslings; R W Poolman; V A B Scholtes
Journal:  Bone Joint Res       Date:  2018-01       Impact factor: 5.853

7.  Disability and return to work after MRI on suspicion of scaphoid fracture: Influence of MRI pathology and occupational mechanical exposures.

Authors:  Lone Kirkeby; Poul Frost; Torben Bæk Hansen; Susanne Wulff Svendsen
Journal:  PLoS One       Date:  2018-06-04       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.